Howard Hughes Medical Institute and Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Lancet. 2010 Apr 10;375(9722):1287-95. doi: 10.1016/S0140-6736(10)60236-X.
Knowledge of the primary cause of a disease is essential for elucidation of its mechanisms, and for adequate classification, prognosis, and treatment. Recently, the causes of many kidney diseases have been shown to be single-gene defects-eg, steroid-resistant nephrotic syndrome, which is caused by podocin mutations in about 25% of children and nearly 15% of adults with the disease. Knowledge of a disease-causing mutation in a single-gene disorder represents one of the most robust diagnostic examples of personalised medicine because the mutation conveys an almost 100% risk of developing the disease by a defined age. Whereas single-gene diseases are rare disorders, polygenic risk alleles arise in common adult-onset diseases. In this Review, I will discuss prominent renal single-gene kidney disorders, and polygenic risk alleles of common disorders. I delineate how emerging techniques of total exome capture and large-scale sequencing will assist molecular genetic diagnosis, prognosis, and specific treatment, and lead to an improved elucidation of disease mechanisms, thus enabling development of new targeted drugs.
了解疾病的主要病因对于阐明其发病机制、进行充分的分类、预后判断和治疗至关重要。最近,许多肾脏疾病的病因已被证实是单基因缺陷,例如,约 25%的儿童和近 15%的成人肾病综合征患者存在足细胞病变,这是由足细胞基因突变引起的。单基因疾病中致病突变的知识代表了个体化医学最有力的诊断范例之一,因为该突变几乎可使患者在特定年龄前 100%地患上该疾病。虽然单基因疾病较为罕见,但多基因风险等位基因在常见的成人发病疾病中存在。在这篇综述中,我将讨论突出的肾脏单基因肾脏疾病和常见疾病的多基因风险等位基因。我将阐述新兴的外显子组捕获和大规模测序技术如何帮助进行分子遗传学诊断、预后判断和特定治疗,并促进对疾病机制的深入了解,从而开发新的靶向药物。